FDA Loosens Restrictions On GSK's Avandia
The U.S. Food and Drug Administration on Monday removed prescribing restrictions on GlaxoSmithKline PLC's onetime blockbuster diabetes medication Avandia, capping a turnaround in the agency's assessment of its cardiovascular risks three...To view the full article, register now.
Already a subscriber? Click here to view full article